Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.

2.

Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors.

Kostareli E, Hadzidimitriou A, Stavroyianni N, Darzentas N, Athanasiadou A, Gounari M, Bikos V, Agathagelidis A, Touloumenidou T, Zorbas I, Kouvatsi A, Laoutaris N, Fassas A, Anagnostopoulos A, Belessi C, Stamatopoulos K.

Leukemia. 2009 May;23(5):919-24. doi: 10.1038/leu.2008.379. Epub 2009 Jan 15.

PMID:
19148139
3.

Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.

Catera R, Silverman GJ, Hatzi K, Seiler T, Didier S, Zhang L, Hervé M, Meffre E, Oscier DG, Vlassara H, Scofield RH, Chen Y, Allen SL, Kolitz J, Rai KR, Chu CC, Chiorazzi N.

Mol Med. 2008 Nov-Dec;14(11-12):665-74. doi: 10.2119/2008-00102.Catera. Epub 2008 Sep 25.

4.

IMGT, the international ImMunoGeneTics information system.

Lefranc MP, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, Wu Y, Gemrot E, Brochet X, Lane J, Regnier L, Ehrenmann F, Lefranc G, Duroux P.

Nucleic Acids Res. 2009 Jan;37(Database issue):D1006-12. doi: 10.1093/nar/gkn838. Epub 2008 Oct 31.

5.

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

Chu CC, Catera R, Hatzi K, Yan XJ, Zhang L, Wang XB, Fales HM, Allen SL, Kolitz JE, Rai KR, Chiorazzi N.

Blood. 2008 Dec 15;112(13):5122-9. doi: 10.1182/blood-2008-06-162024. Epub 2008 Sep 23.

6.

Reduction of B cell turnover in chronic lymphocytic leukaemia.

Defoiche J, Debacq C, Asquith B, Zhang Y, Burny A, Bron D, Lagneaux L, Macallan D, Willems L.

Br J Haematol. 2008 Oct;143(2):240-7. doi: 10.1111/j.1365-2141.2008.07348.x. Epub 2008 Aug 15.

PMID:
18710389
7.

Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.

Cutrona G, Colombo M, Matis S, Fabbi M, Spriano M, Callea V, Vigna E, Gentile M, Zupo S, Chiorazzi N, Morabito F, Ferrarini M.

Haematologica. 2008 Mar;93(3):413-22. doi: 10.3324/haematol.11646. Epub 2008 Feb 20.

8.

A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.

Lanemo Myhrinder A, Hellqvist E, Sidorova E, Söderberg A, Baxendale H, Dahle C, Willander K, Tobin G, Bäckman E, Söderberg O, Rosenquist R, Hörkkö S, Rosén A.

Blood. 2008 Apr 1;111(7):3838-48. doi: 10.1182/blood-2007-11-125450. Epub 2008 Jan 25.

9.

Nonmuscle myosin II moves in new directions.

Conti MA, Adelstein RS.

J Cell Sci. 2008 Jan 1;121(Pt 1):11-8. Erratum in: J Cell Sci. 2008 Feb 1;121(Pt 3):404.

11.

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C, Laoutaris N, Karlsson K, Baran-Marzsak F, Tsaftaris A, Moreno C, Anagnostopoulos A, Caligaris-Cappio F, Vaur D, Ouzounis C, Belessi C, Ghia P, Davi F, Rosenquist R, Stamatopoulos K.

Blood. 2008 Feb 1;111(3):1524-33. Epub 2007 Oct 24.

12.

Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident--with focus on immunoglobulin heavy chain gene analysis.

Abramenko I, Bilous N, Chumak A, Davidova E, Kryachok I, Martina Z, Nechaev S, Dyagil I, Bazyka D, Bebeshko V.

Leuk Res. 2008 Apr;32(4):535-45. Epub 2007 Sep 25.

PMID:
17897714
13.

CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.

Damle RN, Temburni S, Calissano C, Yancopoulos S, Banapour T, Sison C, Allen SL, Rai KR, Chiorazzi N.

Blood. 2007 Nov 1;110(9):3352-9. Epub 2007 Aug 7.

14.

Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics.

Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR.

J Clin Invest. 2007 Mar;117(3):712-8.

15.

Actin-binding protein filamin A is displayed on the surface of human neuroblastoma cells.

Bachmann AS, Howard JP, Vogel CW.

Cancer Sci. 2006 Dec;97(12):1359-65. Epub 2006 Sep 25.

16.

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T, Belhoul L, Stella S, Stavroyianni N, Crespo M, Hadzidimitriou A, Sutton L, Bosch F, Laoutaris N, Anagnostopoulos A, Montserrat E, Fassas A, Dighiero G, Caligaris-Cappio F, Merle-Béral H, Ghia P, Davi F.

Blood. 2007 Jan 1;109(1):259-70. Epub 2006 Sep 19.

17.

Identification of the target self-antigens in reperfusion injury.

Zhang M, Alicot EM, Chiu I, Li J, Verna N, Vorup-Jensen T, Kessler B, Shimaoka M, Chan R, Friend D, Mahmood U, Weissleder R, Moore FD, Carroll MC.

J Exp Med. 2006 Jan 23;203(1):141-52. Epub 2006 Jan 3.

18.
19.

Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.

Hervé M, Xu K, Ng YS, Wardemann H, Albesiano E, Messmer BT, Chiorazzi N, Meffre E.

J Clin Invest. 2005 Jun;115(6):1636-43. Epub 2005 May 2.

20.

The role of IgM antibodies in the recognition and clearance of apoptotic cells.

Peng Y, Kowalewski R, Kim S, Elkon KB.

Mol Immunol. 2005 May;42(7):781-7. Epub 2005 Jan 16. Review.

PMID:
15829266
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk